{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:44:24Z","timestamp":1793745864895,"version":"4.6.1"},"reference-count":255,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-021-00246-5","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T04:52:27Z","timestamp":1613019147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":238,"title":["Penile cancer"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9653-0393","authenticated-orcid":false,"given":"Anita","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-2756","authenticated-orcid":false,"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-4836","authenticated-orcid":false,"given":"Marcos","family":"Tobias-Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Thi Huyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-4486","authenticated-orcid":false,"given":"Anne-Sophie","family":"Van Rompuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5723-1972","authenticated-orcid":false,"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-6586","authenticated-orcid":false,"given":"Maarten","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"246_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MOU.0000000000000581","volume":"29","author":"A Douglawi","year":"2019","unstructured":"Douglawi, A. & Masterson, T. A. Penile cancer epidemiology and risk factors: a contemporary review. Curr. Opin. Urol. 29, 145\u2013149 (2019).","journal-title":"Curr. Opin. Urol."},{"key":"246_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen, T. B. et al. Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 20, 145\u2013158 (2019).","journal-title":"Lancet Oncol."},{"key":"246_CR3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00120-018-0603-9","volume":"57","author":"DL Dr\u00e4ger","year":"2018","unstructured":"Dr\u00e4ger, D. L., Milerski, S., Sievert, K. D. & Hakenberg, O. W. Psychosocial effects in patients with penile cancer: a systematic review. Urologe A 57, 444\u2013452 (2018).","journal-title":"Urologe A"},{"key":"246_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpuro0751","volume":"4","author":"G Novara","year":"2007","unstructured":"Novara, G., Galfano, A., De Marco, V., Artibani, W. & Ficarra, V. Prognostic factors in squamous cell carcinoma of the penis. Nat. Clin. Pract. Urol. 4, 140\u2013146 (2007).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"246_CR5","doi-asserted-by":"crossref","first-page":"159.e7","DOI":"10.1016\/j.urolonc.2017.12.001","volume":"36","author":"SL Woldu","year":"2018","unstructured":"Woldu, S. L. et al. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: a propensity-score matched analysis. Urol. Oncol. 36, 159.e7\u2013159.17 (2018).","journal-title":"Urol. Oncol."},{"key":"246_CR6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1054\/bjps.2002.3825","volume":"55","author":"GL Ross","year":"2002","unstructured":"Ross, G. L. et al. The learning curve for sentinel node biopsy in malignant melanoma. Br. J. Plast. Surg. 55, 298\u2013301 (2002).","journal-title":"Br. J. Plast. Surg."},{"key":"246_CR7","unstructured":"Flaig, T. W. et al. NCCN Guidelines Version 2.2020 Penile Cancer (NCCN, 2020)."},{"key":"246_CR8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg, O. W. et al. EAU guidelines on penile cancer: 2014 update. Eur. Urol. 67, 142\u2013150 (2015).","journal-title":"Eur. Urol."},{"key":"246_CR9","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro, L. C. et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J. Clin. Oncol. 28, 3851\u20133857 (2010).","journal-title":"J. Clin. Oncol."},{"key":"246_CR10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1517\/17460441.2014.925875","volume":"9","author":"G Agarwal","year":"2014","unstructured":"Agarwal, G., Gupta, S. & Spiess, P. E. Novel targeted therapies for the treatment of penile cancer. Expert Opin. Drug Discov. 9, 959\u2013968 (2014).","journal-title":"Expert Opin. Drug Discov."},{"key":"246_CR11","volume":"41","author":"CE Montes Cardona","year":"2017","unstructured":"Montes Cardona, C. E. & Garc\u00eda-Perdomo, H. A. Incidence of penile cancer worldwide: systematic review and meta-analysis. Rev. Panam. Salud Publica 41, e117 (2017).","journal-title":"Rev. Panam. Salud Publica"},{"key":"246_CR12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"246_CR13","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144, 1941\u20131953 (2019).","journal-title":"Int. J. Cancer"},{"key":"246_CR14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/S1677-55382008000500007","volume":"34","author":"LA Favorito","year":"2008","unstructured":"Favorito, L. A. et al. Epidemiologic study on penile cancer in Brazil. Int. Braz. J. Urol. 34, 587\u2013593 (2008).","journal-title":"Int. Braz. J. Urol."},{"key":"246_CR15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejca.2011.10.031","volume":"48","author":"O Visser","year":"2012","unstructured":"Visser, O. et al. Incidence and survival of rare urogenital cancers in Europe. Eur. J. Cancer 48, 456\u2013464 (2012).","journal-title":"Eur. J. Cancer"},{"key":"246_CR16","doi-asserted-by":"crossref","first-page":"415062","DOI":"10.1155\/2009\/415062","volume":"2009","author":"A Rando Sous","year":"2009","unstructured":"Rando Sous, A. et al. A review of penile cancer. Adv. Urol. 2009, 415062 (2009).","journal-title":"Adv. Urol."},{"key":"246_CR17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1055-9965.EPI-07-0221","volume":"16","author":"MT Goodman","year":"2007","unstructured":"Goodman, M. T., Hernandez, B. Y. & Shvetsov, Y. B. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol. Biomarkers Prev. 16, 1833\u20131839 (2007).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"246_CR18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","volume":"191","author":"RS Djajadiningrat","year":"2014","unstructured":"Djajadiningrat, R. S. et al. Contemporary management of regional nodes in penile cancer \u2014 improvement of survival? J. Urol. 191, 68\u201373 (2014).","journal-title":"J. Urol."},{"key":"246_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00345-008-0310-z","volume":"27","author":"LC Pagliaro","year":"2009","unstructured":"Pagliaro, L. C. & Crook, J. Multimodality therapy in penile cancer: when and which treatments? World J. Urol. 27, 221\u2013225 (2009).","journal-title":"World J. Urol."},{"key":"246_CR20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ejca.2012.10.029","volume":"49","author":"RHA Verhoeven","year":"2013","unstructured":"Verhoeven, R. H. A. et al. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur. J. Cancer 49, 1414\u20131421 (2013).","journal-title":"Eur. J. Cancer"},{"key":"246_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-9056(14)60052-X","volume":"13","author":"B Ayres","year":"2014","unstructured":"Ayres, B. et al. Has centralisation of penile cancer services in the United Kingdom improved survival? Eur. Urol. Suppl. 13, e50 (2014).","journal-title":"Eur. Urol. Suppl."},{"key":"246_CR22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00345-019-02866-9","volume":"38","author":"J Vanthoor","year":"2020","unstructured":"Vanthoor, J., Thomas, A., Tsaur, I. & Albersen, M. Making surgery safer by centralization of care: impact of case load in penile cancer. World J. Urol. 38, 1385\u20131390 (2020).","journal-title":"World J. Urol."},{"key":"246_CR23","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ijc.31194","volume":"142","author":"BT Hansen","year":"2018","unstructured":"Hansen, B. T., Orumaa, M., Lie, A. K., Brennhovd, B. & Nygard, M. Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015. Int. J. Cancer 142, 1586\u20131593 (2018).","journal-title":"Int. J. Cancer"},{"key":"246_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00428-019-02607-8","volume":"475","author":"A Emmanuel","year":"2019","unstructured":"Emmanuel, A., Nettleton, J., Watkin, N. & Berney, D. M. The molecular pathogenesis of penile carcinoma-current developments and understanding. Virchows Archiv. 475, 397\u2013405 (2019).","journal-title":"Virchows Archiv."},{"key":"246_CR25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S0365-05962011000200014","volume":"86","author":"M Leto","year":"2011","unstructured":"Leto, M., Santos Junior, G. F., Porro, A. M. & Tomimori, J. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An. Bras. Dermatol. 86, 306\u2013317 (2011).","journal-title":"An. Bras. Dermatol."},{"key":"246_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.critrevonc.2004.09.006","volume":"53","author":"AM Mosconi","year":"2005","unstructured":"Mosconi, A. M., Roila, F., Gatta, G. & Theodore, C. Cancer of the penis. Crit. Rev. Oncol. Hematol. 53, 165\u2013177 (2005).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"246_CR27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3322\/caac.21354","volume":"66","author":"PE Spiess","year":"2016","unstructured":"Spiess, P. E., Dhillon, J., Baumgarten, A. S., Johnstone, P. A. & Giuliano, A. R. Pathophysiological basis of human papillomavirus in penile cancer: key to prevention and delivery of more effective therapies. CA Cancer J. Clin. 66, 481\u2013495 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"246_CR28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","volume":"69","author":"L Alemany","year":"2016","unstructured":"Alemany, L. et al. Role of human papillomavirus in penile carcinomas worldwide. Eur. Urol. 69, 953\u2013961 (2016).","journal-title":"Eur. Urol."},{"key":"246_CR29","doi-asserted-by":"crossref","first-page":"53.e1","DOI":"10.1016\/j.urolonc.2013.08.010","volume":"32","author":"A Flaherty","year":"2014","unstructured":"Flaherty, A. et al. Implications for human papillomavirus in penile cancer. Urol. Oncol. 32, 53.e1\u201353.e8 (2014).","journal-title":"Urol. Oncol."},{"key":"246_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/s1677-5538.ibju.2017.01.03","volume":"43","author":"AA Ornellas","year":"2017","unstructured":"Ornellas, A. A. & Ornellas, P. Should routine neonatal circumcision be a police to prevent penile cancer? Opinion: Yes. Int. Braz. J. Urol. 43, 7\u20139 (2017).","journal-title":"Int. Braz. J. Urol."},{"key":"246_CR31","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.urology.2010.04.007","volume":"76","author":"S Minhas","year":"2010","unstructured":"Minhas, S., Manseck, A., Watya, S. & Hegarty, P. K. Penile cancer \u2014 prevention and premalignant conditions. Urology 76, S24\u2013S35 (2010).","journal-title":"Urology"},{"key":"246_CR32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s10552-011-9785-9","volume":"22","author":"NL Larke","year":"2011","unstructured":"Larke, N. L., Thomas, S. L., dos Santos Silva, I. & Weiss, H. A. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes Control 22, 1097\u20131110 (2011).","journal-title":"Cancer Causes Control"},{"key":"246_CR33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1464-410X.2011.10699.x","volume":"108","author":"D Clouston","year":"2011","unstructured":"Clouston, D., Hall, A. & Lawrentschuk, N. Penile lichen sclerosus (balanitis xerotica obliterans). BJU Int. 108, 14\u201319 (2011).","journal-title":"BJU Int."},{"key":"246_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1464-410X.1995.tb07352.x","volume":"75","author":"K Harish","year":"1995","unstructured":"Harish, K. & Ravi, R. The role of tobacco in penile carcinoma. Br. J. Urol. 75, 375\u2013377 (1995).","journal-title":"Br. J. Urol."},{"key":"246_CR35","doi-asserted-by":"crossref","DOI":"10.1186\/s12894-016-0161-7","volume":"16","author":"KT Barnes","year":"2016","unstructured":"Barnes, K. T. et al. Obesity is associated with increased risk of invasive penile cancer. BMC Urol. 16, 42 (2016).","journal-title":"BMC Urol."},{"key":"246_CR36","volume":"10","author":"CB Vieira","year":"2020","unstructured":"Vieira, C. B. et al. Profile of patients with penile cancer in the region with the highest worldwide incidence. Sci. Rep. 10, 2965 (2020).","journal-title":"Sci. Rep."},{"key":"246_CR37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","volume":"11","author":"PE Clark","year":"2013","unstructured":"Clark, P. E. et al. Penile cancer. J. Natl Compr. Cancer Netw. 11, 594\u2013615 (2013).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"246_CR38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1067\/mjd.2002.124618","volume":"47","author":"RS Stern","year":"2002","unstructured":"Stern, R. S., Bagheri, S. & Nichols, K. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J. Am. Acad. Dermatol. 47, 33\u201339 (2002).","journal-title":"J. Am. Acad. Dermatol."},{"key":"246_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/iju.13871","volume":"26","author":"RJ Hoekstra","year":"2019","unstructured":"Hoekstra, R. J., Trip, E. J., Ten Kate, F. J., Horenblas, S. & Lock, M. T. Penile intraepithelial neoplasia: nomenclature, incidence and progression to malignancy in the Netherlands. Int. J. Urol. 26, 353\u2013357 (2019).","journal-title":"Int. J. Urol."},{"key":"246_CR40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/infdis\/jiu587","volume":"211","author":"DJ Ingles","year":"2015","unstructured":"Ingles, D. J. et al. Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) study. J. Infect. Dis. 211, 1060\u20131067 (2015).","journal-title":"J. Infect. Dis."},{"key":"246_CR41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.eururo.2015.05.032","volume":"69","author":"SL Sudenga","year":"2016","unstructured":"Sudenga, S. L. et al. Genital human papillomavirus infection progression to external genital lesions: the HIM study. Eur. Urol. 69, 166\u2013173 (2016).","journal-title":"Eur. Urol."},{"key":"246_CR42","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1002\/ijc.27397","volume":"131","author":"GO Akogbe","year":"2012","unstructured":"Akogbe, G. O. et al. Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States. Int. J. Cancer 131, E282\u2013E291 (2012).","journal-title":"Int. J. Cancer"},{"key":"246_CR43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2340\/00015555-3083","volume":"99","author":"S Kristiansen","year":"2019","unstructured":"Kristiansen, S. et al. Risk factors for penile intraepithelial neoplasia: a population-based register study in Sweden, 2000-2012. Acta Derm. Venereol. 99, 315\u2013320 (2019).","journal-title":"Acta Derm. Venereol."},{"key":"246_CR44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/bbrc.2001.4838","volume":"283","author":"CS Yoon","year":"2001","unstructured":"Yoon, C. S., Kim, K. D., Park, S. N. & Cheong, S. W. alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem. Biophys. Res. Commun. 283, 668\u2013673 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"246_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.605","volume":"19","author":"T Yugawa","year":"2009","unstructured":"Yugawa, T. & Kiyono, T. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev. Med. Virol. 19, 97\u2013113 (2009).","journal-title":"Rev. Med. Virol."},{"key":"246_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/path.1394","volume":"201","author":"E Ferreux","year":"2003","unstructured":"Ferreux, E. et al. Evidence for at least three alternative mechanisms targeting the p16INK4A\/cyclin D\/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J. Pathol. 201, 109\u2013118 (2003).","journal-title":"J. Pathol."},{"key":"246_CR47","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1268-z","volume":"15","author":"J Steinestel","year":"2015","unstructured":"Steinestel, J. et al. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma. BMC Cancer 15, 220 (2015).","journal-title":"BMC Cancer"},{"key":"246_CR48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/380079a0","volume":"380","author":"AJ Klingelhutz","year":"1996","unstructured":"Klingelhutz, A. J., Foster, S. A. & McDougall, J. K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79\u201382 (1996).","journal-title":"Nature"},{"key":"246_CR49","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1101\/gad.1214704","volume":"18","author":"L Gewin","year":"2004","unstructured":"Gewin, L., Myers, H., Kiyono, T. & Galloway, D. A. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6\/E6-AP complex. Genes Dev. 18, 2269\u20132282 (2004).","journal-title":"Genes Dev."},{"key":"246_CR50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/187221309787158371","volume":"3","author":"N Khansari","year":"2009","unstructured":"Khansari, N., Shakiba, Y. & Mahmoudi, M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov. 3, 73\u201380 (2009).","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"246_CR51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.juro.2011.09.027","volume":"187","author":"AA De Paula","year":"2012","unstructured":"De Paula, A. A. et al. The impact of cyclooxygenase-2 and vascular endothelial growth factor C immunoexpression on the prognosis of penile carcinoma. J. Urol. 187, 134\u2013140 (2012).","journal-title":"J. Urol."},{"key":"246_CR52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough, A. et al. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30, 377\u2013386 (2009).","journal-title":"Carcinogenesis"},{"key":"246_CR53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","volume":"458","author":"M Poetsch","year":"2011","unstructured":"Poetsch, M. et al. Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Archiv. 458, 221\u2013229 (2011).","journal-title":"Virchows Archiv."},{"key":"246_CR54","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/jmv.24833","volume":"89","author":"LA Afonso","year":"2017","unstructured":"Afonso, L. A. et al. Human papillomavirus, Epstein-Barr virus, and methylation status of p16(ink4a) in penile cancer. J. Med. Virol. 89, 1837\u20131843 (2017).","journal-title":"J. Med. Virol."},{"key":"246_CR55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00428-014-1713-4","volume":"466","author":"P Lohneis","year":"2015","unstructured":"Lohneis, P. et al. Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes. Virchows Archiv. 466, 323\u2013331 (2015).","journal-title":"Virchows Archiv."},{"key":"246_CR56","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2018\/e551s","volume":"73","author":"S Herbster","year":"2018","unstructured":"Herbster, S., Paladino, A., de Freitas, S. & Boccardo, E. Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases. Clinics 73, e551s (2018).","journal-title":"Clinics"},{"key":"246_CR57","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/cancers12071796","volume":"12","author":"C Chu","year":"2020","unstructured":"Chu, C. et al. Immunophenotypes based on the tumor immune microenvironment allow for unsupervised penile cancer patient stratification. Cancers 12, 1796 (2020).","journal-title":"Cancers"},{"key":"246_CR58","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.humpath.2014.01.012","volume":"45","author":"S Gunia","year":"2014","unstructured":"Gunia, S. et al. Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer. Hum. Pathol. 45, 1169\u20131176 (2014).","journal-title":"Hum. Pathol."},{"key":"246_CR59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fimmu.2018.01253","volume":"9","author":"SR Ottenhof","year":"2018","unstructured":"Ottenhof, S. R. et al. The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma. Front. Immunol. 9, 1253 (2018).","journal-title":"Front. Immunol."},{"key":"246_CR60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41585-020-0359-z","volume":"17","author":"AM Aydin","year":"2020","unstructured":"Aydin, A. M. et al. Understanding genomics and the immune environment of penile cancer to improve therapy. Nat. Rev. Urol. 17, 555\u2013570 (2020).","journal-title":"Nat. Rev. Urol."},{"key":"246_CR61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12866-020-01759-x","volume":"20","author":"H Onywera","year":"2020","unstructured":"Onywera, H. et al. The penile microbiota of Black South African men: relationship with human papillomavirus and HIV infection. BMC Microbiol. 20, 78 (2020).","journal-title":"BMC Microbiol."},{"key":"246_CR62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.aaf2834","volume":"352","author":"CU Blank","year":"2016","unstructured":"Blank, C. U., Haanen, J. B., Ribas, A. & Schumacher, T. N. Cancer immunology. The \u201ccancer immunogram\u201d. Science 352, 658\u2013660 (2016).","journal-title":"Science"},{"key":"246_CR63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.eururo.2018.09.022","volume":"75","author":"N van dijk","year":"2019","unstructured":"van dijk, N. et al. The cancer immunogram as a framework for personalized immunotherapy in urothelial cancer. Eur. Urol. 75, 435\u2013444 (2019).","journal-title":"Eur. Urol."},{"key":"246_CR64","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euf.2019.02.019","volume":"5","author":"HM de Vries","year":"2019","unstructured":"de Vries, H. M., Ottenhof, S. R., Horenblas, S., van der Heijden, M. S. & Jordanova, E. S. Defining the tumor microenvironment of penile cancer by means of the cancer immunogram. Eur. Urol. Focus. 5, 718\u2013721 (2019).","journal-title":"Eur. Urol. Focus."},{"key":"246_CR65","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.23743","volume":"113","author":"BY Hernandez","year":"2008","unstructured":"Hernandez, B. Y. et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998\u20132003. Cancer 113, 2883\u20132891 (2008).","journal-title":"Cancer"},{"key":"246_CR66","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.urolonc.2006.08.029","volume":"25","author":"JS Barnholtz-Sloan","year":"2007","unstructured":"Barnholtz-Sloan, J. S., Maldonado, J. L., Pow-sang, J. & Giuliano, A. R. Incidence trends in primary malignant penile cancer. Urol. Oncol. 25, 361\u2013367 (2007).","journal-title":"Urol. Oncol."},{"key":"246_CR67","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/S1677-55382008000500007","volume":"34","author":"LA Favorito","year":"2008","unstructured":"Favorito, L. A. et al. Epidemiologic study on penile cancer in Brazil. Int. Braz. J. Urol. 34, 587\u2013591 (2008).","journal-title":"Int. Braz. J. Urol."},{"key":"246_CR68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MD.0b013e318239add6","volume":"91","author":"JF Dufour","year":"2012","unstructured":"Dufour, J. F. et al. Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine 91, 67\u201374 (2012).","journal-title":"Medicine"},{"key":"246_CR69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.ju.0000070820.91387.55","volume":"170","author":"DK Lee","year":"2003","unstructured":"Lee, D. K., Hinshaw, M., Cripps, D. & Jarrard, D. F. Pyoderma gangrenosum of penis. J. Urol. 170, 185\u2013186 (2003).","journal-title":"J. Urol."},{"key":"246_CR70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijmyco.2016.04.003","volume":"5","author":"D Khan","year":"2016","unstructured":"Khan, D., Choudhary, A., Dutta, A. & Khan, I. Tuberculosis of the glans penis mimicking as carcinoma. Int. J. Mycobacteriol. 5, 341\u2013342 (2016).","journal-title":"Int. J. Mycobacteriol."},{"key":"246_CR71","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00120-009-2062-9","volume":"48","author":"I Tsaur","year":"2009","unstructured":"Tsaur, I., Ochsendorf, F. R., Bug, R. & Jonas, D. Primary syphilitic lesion mimicking penile cancer. Atypical manifestation with an unconventional diagnostic approach. Urologe A 48, 1210\u20131213 (2009).","journal-title":"Urologe A"},{"key":"246_CR72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1464-410X.2003.04119.x","volume":"91","author":"AP Lont","year":"2003","unstructured":"Lont, A. P., Besnard, A. P., Gallee, M. P., van Tinteren, H. & Horenblas, S. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 91, 493\u2013495 (2003).","journal-title":"BJU Int."},{"key":"246_CR73","doi-asserted-by":"crossref","first-page":"i4337","DOI":"10.1136\/bmj.i4337","volume":"354","author":"TN Shim","year":"2016","unstructured":"Shim, T. N., Ali, I., Muneer, A. & Bunker, C. B. Benign male genital dermatoses. Br. Med. J. 354, i4337 (2016).","journal-title":"Br. Med. J."},{"key":"246_CR74","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/sti.2009.036061","volume":"85","author":"MA Lucky","year":"2009","unstructured":"Lucky, M. A., Rogers, B. & Parr, N. J. Referrals into a dedicated British penile cancer centre and sources of possible delay. Sex. Transm. Infect. 85, 527\u2013530 (2009).","journal-title":"Sex. Transm. Infect."},{"key":"246_CR75","doi-asserted-by":"crossref","first-page":"vi115","DOI":"10.1093\/annonc\/mdt286","volume":"24","author":"H Van Poppel","year":"2013","unstructured":"Van Poppel, H. et al. Penile cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24, vi115\u2013vi124 (2013).","journal-title":"Ann. Oncol."},{"key":"246_CR76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/85.1.19","volume":"85","author":"C Maden","year":"1993","unstructured":"Maden, C. et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J. Natl Cancer Inst. 85, 19\u201324 (1993).","journal-title":"J. Natl Cancer Inst."},{"key":"246_CR77","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ijc.21009","volume":"116","author":"JR Daling","year":"2005","unstructured":"Daling, J. R. et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int. J. Cancer 116, 606\u2013616 (2005).","journal-title":"Int. J. Cancer"},{"key":"246_CR78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/1097-0096(200010)28:8<399::AID-JCU4>3.0.CO;2-J","volume":"28","author":"A Agrawal","year":"2000","unstructured":"Agrawal, A., Pai, D., Ananthakrishnan, N., Smile, S. R. & Ratnakar, C. Clinical and sonographic findings in carcinoma of the penis. J. Clin. Ultrasound 28, 399\u2013406 (2000).","journal-title":"J. Clin. Ultrasound"},{"key":"246_CR79","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0090-4295(94)90189-9","volume":"43","author":"S Horenblas","year":"1994","unstructured":"Horenblas, S., Kr\u00f6ger, R., Gallee, M. P., Newling, D. W. & van Tinteren, H. Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology 43, 702\u2013707 (1994).","journal-title":"Urology"},{"key":"246_CR80","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.eururo.2006.11.014","volume":"51","author":"O Kayes","year":"2007","unstructured":"Kayes, O. et al. The role of magnetic resonance imaging in the local staging of penile cancer. Eur. Urol. 51, 1313\u20131318 (2007).","journal-title":"Eur. Urol."},{"key":"246_CR81","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11547-008-0273-6","volume":"113","author":"G Petralia","year":"2008","unstructured":"Petralia, G. et al. Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection. Radiol. Med. 113, 517\u2013528 (2008).","journal-title":"Radiol. Med."},{"key":"246_CR82","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.urolonc.2010.09.015","volume":"30","author":"HM Rosevear","year":"2012","unstructured":"Rosevear, H. M. et al. Utility of \u00b9-F-FDG PET\/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Urol. Oncol. 30, 723\u2013726 (2012).","journal-title":"Urol. Oncol."},{"key":"246_CR83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/RLU.0b013e318238f6ea","volume":"37","author":"R Sadeghi","year":"2012","unstructured":"Sadeghi, R., Gholami, H., Zakavi, S. R., Kakhki, V. R. & Horenblas, S. Accuracy of 18F-FDG PET\/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin. Nucl. Med. 37, 436\u2013441 (2012).","journal-title":"Clin. Nucl. Med."},{"key":"246_CR84","doi-asserted-by":"crossref","first-page":"833","DOI":"10.21037\/tau.2017.04.36","volume":"6","author":"SR Ottenhof","year":"2017","unstructured":"Ottenhof, S. R. & Vegt, E. The role of PET\/CT imaging in penile cancer. Transl. Androl. Urol. 6, 833\u2013838 (2017).","journal-title":"Transl. Androl. Urol."},{"key":"246_CR85","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2010.09.039","volume":"59","author":"M Shabbir","year":"2011","unstructured":"Shabbir, M. et al. Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur. Urol. 59, 142\u2013147 (2011).","journal-title":"Eur. Urol."},{"key":"246_CR86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E. & Ulbright, T. M. The 2016 WHO classification of tumours of the urinary system and male genital organs \u2014 part a: renal, penile, and testicular tumours. Eur. Urol. 70, 93\u2013105 (2016).","journal-title":"Eur. Urol."},{"key":"246_CR87","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.urology.2010.02.038","volume":"76","author":"A Chaux","year":"2010","unstructured":"Chaux, A., Velazquez, E. F., Algaba, F., Ayala, G. & Cubilla, A. L. Developments in the pathology of penile squamous cell carcinomas. Urology 76, S7\u2013S14 (2010).","journal-title":"Urology"},{"key":"246_CR88","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5858\/134.6.923","volume":"134","author":"EF Velazquez","year":"2010","unstructured":"Velazquez, E. F. et al. Protocol for the examination of specimens from patients with carcinoma of the penis. Arch. Pathol. Lab. Med. 134, 923\u2013929 (2010).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"246_CR89","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","volume":"73","author":"GP Paner","year":"2018","unstructured":"Paner, G. P. et al. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur. Urol. 73, 560\u2013569 (2018).","journal-title":"Eur. Urol."},{"key":"246_CR90","unstructured":"Amin, M. B. et al. AJCC Cancer Staging Manual 8th edn (Springer, 2017)."},{"key":"246_CR91","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3389\/fimmu.2018.02478","volume":"9","author":"M Dadar","year":"2018","unstructured":"Dadar, M. et al. Advances in designing and developing vaccines, drugs and therapeutic approaches to counter human papilloma virus. Front. Immunol. 9, 2478 (2018).","journal-title":"Front. Immunol."},{"key":"246_CR92","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","volume":"2","author":"M Schiffman","year":"2016","unstructured":"Schiffman, M. et al. Carcinogenic human papillomavirus infection. Nat. Rev. Dis. Prim. 2, 16086 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"246_CR93","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.4161\/hv.29137","volume":"10","author":"M Stanley","year":"2014","unstructured":"Stanley, M. HPV vaccination in boys and men. Hum. Vaccin. Immunother. 10, 2109\u20132111 (2014).","journal-title":"Hum. Vaccin. Immunother."},{"key":"246_CR94","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.vaccine.2018.03.024","volume":"36","author":"SS Ng","year":"2018","unstructured":"Ng, S. S., Hutubessy, R. & Chaiyakunapruk, N. Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-valent vaccine, gender-neutral and multiple age cohort vaccination. Vaccine 36, 2529\u20132544 (2018).","journal-title":"Vaccine"},{"key":"246_CR95","doi-asserted-by":"crossref","first-page":"k3837","DOI":"10.1136\/bmj.k3837","volume":"362","author":"N Powell","year":"2018","unstructured":"Powell, N., Hibbitts, S. & Evans, M. Gender neutral vaccination against HPV. Br. Med. J. 362, k3837 (2018).","journal-title":"Br. Med. J."},{"key":"246_CR96","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","volume":"208","author":"LE Markowitz","year":"2013","unstructured":"Markowitz, L. E. et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J. Infect. Dis. 208, 385\u2013393 (2013).","journal-title":"J. Infect. Dis."},{"key":"246_CR97","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","volume":"30","author":"JT Schiller","year":"2012","unstructured":"Schiller, J. T., Castellsagu\u00e9, X. & Garland, S. M. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30, F123\u2013F138 (2012).","journal-title":"Vaccine"},{"key":"246_CR98","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009915","volume":"6","author":"D Mesher","year":"2016","unstructured":"Mesher, D., Panwar, K., Thomas, S. L., Beddows, S. & Soldan, K. Continuing reductions in HPV 16\/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study. BMJ Open 6, e009915 (2016).","journal-title":"BMJ Open"},{"key":"246_CR99","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano, A. R. et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N. Engl. J. Med. 364, 401\u2013411 (2011).","journal-title":"N. Engl. J. Med."},{"key":"246_CR100","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky, J. M. et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N. Engl. J. Med. 365, 1576\u20131585 (2011).","journal-title":"N. Engl. J. Med."},{"key":"246_CR101","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1756287212465456","volume":"5","author":"M Shabbir","year":"2013","unstructured":"Shabbir, M., Barod, R., Hegarty, P. K. & Minhas, S. Primary prevention and vaccination for penile cancer. Ther. Adv. Urol. 5, 161\u2013169 (2013).","journal-title":"Ther. Adv. Urol."},{"key":"246_CR102","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12962-015-0029-9","volume":"13","author":"J Olsen","year":"2015","unstructured":"Olsen, J. & J\u00f8rgensen, T. R. Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females. Cost. Eff. Resour. Alloc. 13, 4 (2015).","journal-title":"Cost. Eff. Resour. Alloc."},{"key":"246_CR103","doi-asserted-by":"crossref","first-page":"F157","DOI":"10.1016\/j.vaccine.2012.06.091","volume":"30","author":"K Canfell","year":"2012","unstructured":"Canfell, K. et al. Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine 30, F157\u2013F167 (2012).","journal-title":"Vaccine"},{"key":"246_CR104","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MOU.0000000000000587","volume":"29","author":"Y Raskin","year":"2019","unstructured":"Raskin, Y., Vanthoor, J., Milenkovic, U., Muneer, A. & Albersen, M. Organ-sparing surgical and nonsurgical modalities in primary penile cancer treatment. Curr. Opin. Urol. 29, 156\u2013164 (2019).","journal-title":"Curr. Opin. Urol."},{"key":"246_CR105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ucl.2016.06.005","volume":"43","author":"J Crook","year":"2016","unstructured":"Crook, J. Contemporary role of radiotherapy in the management of primary penile tumors and metastatic disease. Urol. Clin. North Am. 43, 435\u2013448 (2016).","journal-title":"Urol. Clin. North Am."},{"key":"246_CR106","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2018.04.025","volume":"74","author":"J Chipollini","year":"2018","unstructured":"Chipollini, J., Necchi, A. & Spiess, P. E. Outcomes for patients with node-positive penile cancer: impact of perioperative systemic therapies and the importance of surgical intervention. Eur. Urol. 74, 241\u2013242 (2018).","journal-title":"Eur. Urol."},{"key":"246_CR107","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MOU.0000000000000719","volume":"30","author":"M Bandini","year":"2020","unstructured":"Bandini, M., Pederzoli, F. & Necchi, A. Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge. Curr. Opin. Urol. 30, 218\u2013222 (2020).","journal-title":"Curr. Opin. Urol."},{"key":"246_CR108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2018.04.003","volume":"74","author":"R Robinson","year":"2018","unstructured":"Robinson, R. et al. Risks and benefits of adjuvant radiotherapy after inguinal lymphadenectomy in node-positive penile cancer: a systematic review by the european association of urology penile cancer guidelines panel. Eur. Urol. 74, 76\u201383 (2018).","journal-title":"Eur. Urol."},{"key":"246_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-020-0327-4","author":"S Ashley","year":"2020","unstructured":"Ashley, S. et al. Human papilloma virus (HPV) status may impact treatment outcomes in patients with pre-cancerous penile lesions (an eUROGEN Study). Int. J. Impot. Res. https:\/\/doi.org\/10.1038\/s41443-020-0327-4 (2020).","journal-title":"Int. J. Impot. Res."},{"key":"246_CR110","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1800574","author":"G Kravvas","year":"2020","unstructured":"Kravvas, G. et al. The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature. J. Dermatol. Treat. https:\/\/doi.org\/10.1080\/09546634.2020.1800574 (2020).","journal-title":"J. Dermatol. Treat."},{"key":"246_CR111","doi-asserted-by":"crossref","first-page":"803","DOI":"10.21037\/tau.2017.06.24","volume":"6","author":"A Manjunath","year":"2017","unstructured":"Manjunath, A., Brenton, T., Wylie, S., Corbishley, C. M. & Watkin, N. A. Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity. Transl. Androl. Urol. 6, 803\u2013808 (2017).","journal-title":"Transl. Androl. Urol."},{"key":"246_CR112","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eururo.2012.02.052","volume":"62","author":"HM Alnajjar","year":"2012","unstructured":"Alnajjar, H. M. et al. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur. Urol. 62, 923\u2013928 (2012).","journal-title":"Eur. Urol."},{"key":"246_CR113","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12466","volume":"58","author":"K Deen","year":"2017","unstructured":"Deen, K. & Burdon-Jones, D. Imiquimod in the treatment of penile intraepithelial neoplasia: an update. Australas. J. Dermatol. 58, 86\u201392 (2017).","journal-title":"Australas. J. Dermatol."},{"key":"246_CR114","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.eururo.2008.01.019","volume":"54","author":"G Bandieramonte","year":"2008","unstructured":"Bandieramonte, G. et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur. Urol. 54, 875\u2013882 (2008).","journal-title":"Eur. Urol."},{"key":"246_CR115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urolonc.2017.09.028","volume":"36","author":"DH Tang","year":"2018","unstructured":"Tang, D. H. et al. Laser ablation as monotherapy for penile squamous cell carcinoma: a multi-center cohort analysis. Urol. Oncol. 36, 147\u2013152 (2018).","journal-title":"Urol. Oncol."},{"key":"246_CR116","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0022-5347(05)65650-9","volume":"166","author":"BP van Bezooijen","year":"2001","unstructured":"van Bezooijen, B. P., Horenblas, S., Meinhardt, W. & Newling, D. W. Laser therapy for carcinoma in situ of the penis. J. Urol. 166, 1670\u20131671 (2001).","journal-title":"J. Urol."},{"key":"246_CR117","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00120-018-0609-3","volume":"57","author":"C Protzel","year":"2018","unstructured":"Protzel, C. & Hakenberg, O. W. Local treatment of penile cancer. Urologe A 57, 423\u2013427 (2018).","journal-title":"Urologe A"},{"key":"246_CR118","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jdcr.2017.07.018","volume":"3","author":"KS Shaw","year":"2017","unstructured":"Shaw, K. S., Nguyen, G. H., Lacouture, M. & Deng, L. Combination of imiquimod with cryotherapy in the treatment of penile intraepithelial neoplasia. JAAD Case Rep. 3, 546\u2013549 (2017).","journal-title":"JAAD Case Rep."},{"key":"246_CR119","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2340\/00015555-0130","volume":"86","author":"J Paoli","year":"2006","unstructured":"Paoli, J. et al. Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Derm. Venereol. 86, 418\u2013421 (2006).","journal-title":"Acta Derm. Venereol."},{"key":"246_CR120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bju.14037","volume":"121","author":"J Chipollini","year":"2018","unstructured":"Chipollini, J. et al. Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature. BJU Int. 121, 393\u2013398 (2018).","journal-title":"BJU Int."},{"key":"246_CR121","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bju.14222","volume":"122","author":"D Sri","year":"2018","unstructured":"Sri, D. et al. A study into the association between local recurrence rates and surgical resection margins in organ-sparing surgery for penile squamous cell cancer. BJU Int. 122, 576\u2013582 (2018).","journal-title":"BJU Int."},{"key":"246_CR122","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1464-410x.2000.00413.x","volume":"85","author":"A Agrawal","year":"2000","unstructured":"Agrawal, A., Pai, D., Ananthakrishnan, N., Smile, S. R. & Ratnakar, C. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int. 85, 299\u2013301 (2000).","journal-title":"BJU Int."},{"key":"246_CR123","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1464-410X.2005.05769.x","volume":"96","author":"S Minhas","year":"2005","unstructured":"Minhas, S. et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 96, 1040\u20131043 (2005).","journal-title":"BJU Int."},{"key":"246_CR124","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","volume":"188","author":"P Philippou","year":"2012","unstructured":"Philippou, P. et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J. Urol. 188, 803\u2013808 (2012).","journal-title":"J. Urol."},{"key":"246_CR125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.juro.2013.12.038","volume":"192","author":"RS Djajadiningrat","year":"2014","unstructured":"Djajadiningrat, R. S. et al. Penile sparing surgery for penile cancer \u2014 does it affect survival? J. Urol. 192, 120\u2013125 (2014).","journal-title":"J. Urol."},{"key":"246_CR126","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15297","author":"E Roussel","year":"2020","unstructured":"Roussel, E. et al. Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma? BJU Int. https:\/\/doi.org\/10.1111\/bju.15297 (2020).","journal-title":"BJU Int."},{"key":"246_CR127","first-page":"82.e87","volume":"36","author":"MH Kamel","year":"2018","unstructured":"Kamel, M. H. et al. Survival outcomes of organ sparing surgery, partial penectomy, and total penectomy in pathological T1\/T2 penile cancer: Report from the National Cancer Data Base. Urol. Oncol. 36, 82.e87\u201382.e15 (2018).","journal-title":"Urol. Oncol."},{"key":"246_CR128","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.juro.2017.10.045","volume":"199","author":"A Baumgarten","year":"2018","unstructured":"Baumgarten, A. et al. Penile sparing surgery for penile cancer: a multicenter international retrospective cohort. J. Urol. 199, 1233\u20131237 (2018).","journal-title":"J. Urol."},{"key":"246_CR129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urolonc.2017.07.025","volume":"36","author":"M Albersen","year":"2018","unstructured":"Albersen, M. et al. Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma. Urol. Oncol. 36, 141\u2013146 (2018).","journal-title":"Urol. Oncol."},{"key":"246_CR130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOU.0000000000000711","volume":"30","author":"HM Alnajjar","year":"2020","unstructured":"Alnajjar, H. M., Randhawa, K. & Muneer, A. Localized disease: types of reconstruction\/plastic surgery techniques after glans resurfacing\/glansectomy\/partial\/total penectomy. Curr. Opin. Urol. 30, 213\u2013217 (2020).","journal-title":"Curr. Opin. Urol."},{"key":"246_CR131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urology.2020.03.058","volume":"142","author":"J P\u00e9rez","year":"2020","unstructured":"P\u00e9rez, J. et al. Oncological and functional outcomes after organ-sparing plastic reconstructive surgery for penile cancer. Urology 142, 161\u2013165.e1 (2020).","journal-title":"Urology"},{"key":"246_CR132","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrurol.2016.54","volume":"13","author":"AL Burnett","year":"2016","unstructured":"Burnett, A. L. Penile preserving and reconstructive surgery in the management of penile cancer. Nat. Rev. Urol. 13, 249\u2013257 (2016).","journal-title":"Nat. Rev. Urol."},{"key":"246_CR133","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/iju5.12076","volume":"2","author":"Y Kitamura","year":"2019","unstructured":"Kitamura, Y. et al. Penile-preserving surgery for male distal urethral carcinoma followed by buccal mucosa urethroplasty. IJU Case Rep. 2, 198\u2013201 (2019).","journal-title":"IJU Case Rep."},{"key":"246_CR134","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000064857","volume":"65","author":"V Ficarra","year":"2000","unstructured":"Ficarra, V. et al. General state of health and psychological well-being in patients after surgery for urological malignant neoplasms. Urol. Int. 65, 130\u2013134 (2000).","journal-title":"Urol. Int."},{"key":"246_CR135","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0360-3016(97)00068-0","volume":"38","author":"R Sarin","year":"1997","unstructured":"Sarin, R., Norman, A. R., Steel, G. G. & Horwich, A. Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int. J. Radiat. Oncol. Biol. Phys. 38, 713\u2013722 (1997).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"246_CR136","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-8140(95)01574-Z","volume":"36","author":"R Rozan","year":"1995","unstructured":"Rozan, R. et al. Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother. Oncol. 36, 83\u201393 (1995).","journal-title":"Radiother. Oncol."},{"key":"246_CR137","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00345-008-0309-5","volume":"27","author":"J Crook","year":"2009","unstructured":"Crook, J., Ma, C. & Grimard, L. Radiation therapy in the management of the primary penile tumor: an update. World J. Urol. 27, 189\u2013196 (2009).","journal-title":"World J. Urol."},{"key":"246_CR138","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijrobp.2008.09.054","volume":"74","author":"R de Crevoisier","year":"2009","unstructured":"de Crevoisier, R. et al. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int. J. Radiat. Oncol. Biol. Phys. 74, 1150\u20131156 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"246_CR139","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0360-3016(93)90008-J","volume":"25","author":"M McLean","year":"1993","unstructured":"McLean, M. et al. The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int. J. Radiat. Oncol. Biol. Phys. 25, 623\u2013628 (1993).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"246_CR140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0936-6555(05)80230-4","volume":"5","author":"F Neave","year":"1993","unstructured":"Neave, F., Neal, A. J., Hoskin, P. J. & Hope-Stone, H. F. Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin. Oncol. 5, 207\u2013210 (1993).","journal-title":"Clin. Oncol."},{"key":"246_CR141","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000020298","volume":"38","author":"D Gotsadze","year":"2000","unstructured":"Gotsadze, D., Matveev, B., Zak, B. & Mamaladze, V. Is conservative organ-sparing treatment of penile carcinoma justified? Eur. Urol. 38, 306\u2013312 (2000).","journal-title":"Eur. Urol."},{"key":"246_CR142","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0959-8049(00)00368-3","volume":"37","author":"A Zouhair","year":"2001","unstructured":"Zouhair, A. et al. Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis? Eur. J. Cancer 37, 198\u2013203 (2001).","journal-title":"Eur. J. Cancer"},{"key":"246_CR143","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.brachy.2015.03.008","volume":"14","author":"S Hasan","year":"2015","unstructured":"Hasan, S. et al. The role of brachytherapy in organ preservation for penile cancer: a meta-analysis and review of the literature. Brachytherapy 14, 517\u2013524 (2015).","journal-title":"Brachytherapy"},{"key":"246_CR144","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MOU.0000000000000346","volume":"27","author":"J Crook","year":"2017","unstructured":"Crook, J. Radiotherapy approaches for locally advanced penile cancer: neoadjuvant and adjuvant. Curr. Opin. Urol. 27, 62\u201367 (2017).","journal-title":"Curr. Opin. Urol."},{"key":"246_CR145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.21037\/tau.2017.07.02","volume":"6","author":"MA Korzeniowski","year":"2017","unstructured":"Korzeniowski, M. A. & Crook, J. M. Contemporary role of radiotherapy in the management of penile cancer. Transl. Androl. Urol. 6, 855\u2013867 (2017).","journal-title":"Transl. Androl. Urol."},{"key":"246_CR146","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrurol.2017.47","volume":"14","author":"A Leone","year":"2017","unstructured":"Leone, A., Diorio, G. J., Pettaway, C., Master, V. & Spiess, P. E. Contemporary management of patients with penile cancer and lymph node metastasis. Nat. Rev. Urol. 14, 335\u2013347 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"246_CR147","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","volume":"76","author":"V Ficarra","year":"2010","unstructured":"Ficarra, V., Akduman, B., Bouchot, O., Palou, J. & Tobias-Machado, M. Prognostic factors in penile cancer. Urology 76, S66\u2013S73 (2010).","journal-title":"Urology"},{"key":"246_CR148","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-5347(17)35221-7","volume":"151","author":"S Horenblas","year":"1994","unstructured":"Horenblas, S. & van Tinteren, H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J. Urol. 151, 1239\u20131243 (1994).","journal-title":"J. Urol."},{"key":"246_CR149","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","volume":"191","author":"RS Djajadiningrat","year":"2014","unstructured":"Djajadiningrat, R. S. et al. Contemporary management of regional nodes in penile cancer-improvement of survival? J. Urol. 191, 68\u201373 (2014).","journal-title":"J. Urol."},{"key":"246_CR150","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0022-5347(17)44281-9","volume":"137","author":"V Srinivas","year":"1987","unstructured":"Srinivas, V., Morse, M. J., Herr, H. W., Sogani, P. C. & Whitmore, W. F. Jr. Penile cancer: relation of extent of nodal metastasis to survival. J. Urol. 137, 880\u2013882 (1987).","journal-title":"J. Urol."},{"key":"246_CR151","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1464-410X.2005.05330.x","volume":"95","author":"BK Kroon","year":"2005","unstructured":"Kroon, B. K., Horenblas, S., Deurloo, E. E., Nieweg, O. E. & Teertstra, H. J. Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int. 95, 517\u2013521 (2005).","journal-title":"BJU Int."},{"key":"246_CR152","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.juro.2010.10.058","volume":"185","author":"NM Graafland","year":"2011","unstructured":"Graafland, N. M., Teertstra, H. J., Besnard, A. P., van Boven, H. H. & Horenblas, S. Identification of high risk pathological node positive penile carcinoma: value of preoperative computerized tomography imaging. J. Urol. 185, 881\u2013887 (2011).","journal-title":"J. Urol."},{"key":"246_CR153","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.eururo.2009.07.004","volume":"57","author":"BE Hughes","year":"2010","unstructured":"Hughes, B. E. et al. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience. Eur. Urol. 57, 688\u2013692 (2010).","journal-title":"Eur. Urol."},{"key":"246_CR154","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2010.08.015","volume":"58","author":"NM Graafland","year":"2010","unstructured":"Graafland, N. M. et al. Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur. Urol. 58, 742\u2013747 (2010).","journal-title":"Eur. Urol."},{"key":"246_CR155","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1464-410X.2006.06296.x","volume":"98","author":"PK Hegarty","year":"2006","unstructured":"Hegarty, P. K. et al. A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. BJU Int. 98, 526\u2013531 (2006).","journal-title":"BJU Int."},{"key":"246_CR156","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.urolonc.2011.02.020","volume":"31","author":"CE Ercole","year":"2013","unstructured":"Ercole, C. E., Pow-Sang, J. M. & Spiess, P. E. Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer. Urol. Oncol. 31, 505\u2013516 (2013).","journal-title":"Urol. Oncol."},{"key":"246_CR157","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","volume":"173","author":"BK Kroon","year":"2005","unstructured":"Kroon, B. K. et al. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J. Urol. 173, 816\u2013819 (2005).","journal-title":"J. Urol."},{"key":"246_CR158","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.juro.2008.06.028","volume":"180","author":"AA Ornellas","year":"2008","unstructured":"Ornellas, A. A. et al. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute. J. Urol. 180, 1354\u20131359 (2008).","journal-title":"J. Urol."},{"key":"246_CR159","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bju.12993","volume":"117","author":"P Kirrander","year":"2016","unstructured":"Kirrander, P., Sherif, A., Friedrich, B., Lambe, M. & H\u00e5kansson, U. Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival. BJU Int. 117, 287\u2013292 (2016).","journal-title":"BJU Int."},{"key":"246_CR160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.eururo.2012.10.035","volume":"63","author":"W Lam","year":"2013","unstructured":"Lam, W. et al. Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: a prospective study of the long-term outcome of 500 inguinal basins assessed at a single institution. Eur. Urol. 63, 657\u2013663 (2013).","journal-title":"Eur. Urol."},{"key":"246_CR161","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2967\/jnumed.112.103127","volume":"53","author":"OR Brouwer","year":"2012","unstructured":"Brouwer, O. R. et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT\/CT. J. Nucl. Med. 53, 1034\u20131040 (2012).","journal-title":"J. Nucl. Med."},{"key":"246_CR162","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2020.09.007","volume":"78","author":"P Dell\u2019Oglio","year":"2020","unstructured":"Dell\u2019Oglio, P. et al. Hybrid indocyanine green\u2013(99m)Tc\u2013nanocolloid for single-photon emission computed tomography and combined radio- and fluorescence-guided sentinel node biopsy in penile cancer: results of 740 inguinal basins assessed at a single institution. Eur. Urol. 78, 865\u2013872 (2020).","journal-title":"Eur. Urol."},{"key":"246_CR163","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/01.ju.0000124485.34430.15","volume":"171","author":"BK Kroon","year":"2004","unstructured":"Kroon, B. K. et al. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J. Urol. 171, 2191\u20132194 (2004).","journal-title":"J. Urol."},{"key":"246_CR164","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bju.13243","volume":"118","author":"JK Jakobsen","year":"2016","unstructured":"Jakobsen, J. K. et al. DaPeCa-3: promising results of sentinel node biopsy combined with (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in clinically lymph node-negative patients with penile cancer \u2013 a national study from Denmark. BJU Int. 118, 102\u2013111 (2016).","journal-title":"BJU Int."},{"key":"246_CR165","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.ju.0000156733.99684.9c","volume":"173","author":"BK Kroon","year":"2005","unstructured":"Kroon, B. K., Lont, A. P., Vald\u00e9s Olmos, R. A., Nieweg, O. E. & Horenblas, S. Morbidity of dynamic sentinel node biopsy in penile carcinoma. J. Urol. 173, 813\u2013815 (2005).","journal-title":"J. Urol."},{"key":"246_CR166","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2008.20.6870","volume":"27","author":"JA Leijte","year":"2009","unstructured":"Leijte, J. A. et al. Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J. Clin. Oncol. 27, 3325\u20133329 (2009).","journal-title":"J. Clin. Oncol."},{"key":"246_CR167","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.juro.2007.01.125","volume":"177","author":"PE Spiess","year":"2007","unstructured":"Spiess, P. E. et al. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J. Urol. 177, 2157\u20132161 (2007).","journal-title":"J. Urol."},{"key":"246_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.07.026","author":"R Nabavizadeh","year":"2020","unstructured":"Nabavizadeh, R. et al. Inguinal lymph node dissection in the era of minimally invasive surgical technology. Urol. Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2020.07.026 (2020).","journal-title":"Urol. Oncol."},{"key":"246_CR169","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3390\/jcm9082501","volume":"9","author":"R Nabavizadeh","year":"2020","unstructured":"Nabavizadeh, R. et al. Utility of minimally invasive technology for inguinal lymph node dissection in penile cancer. J. Clin. Med. 9, 2501 (2020).","journal-title":"J. Clin. Med."},{"key":"246_CR170","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.eururo.2009.02.021","volume":"55","author":"C Protzel","year":"2009","unstructured":"Protzel, C. et al. Lymphadenectomy in the surgical management of penile cancer. Eur. Urol. 55, 1075\u20131088 (2009).","journal-title":"Eur. Urol."},{"key":"246_CR171","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-5347(17)41589-8","volume":"140","author":"WJ Catalona","year":"1988","unstructured":"Catalona, W. J. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J. Urol. 140, 306\u2013310 (1988).","journal-title":"J. Urol."},{"key":"246_CR172","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/iju.IJU_221_19","volume":"36","author":"D Niyogi","year":"2020","unstructured":"Niyogi, D., Noronha, J., Pal, M., Bakshi, G. & Prakash, G. Management of clinically node-negative groin in patients with penile cancer. Indian J. Urol. 36, 8\u201315 (2020).","journal-title":"Indian J. Urol."},{"key":"246_CR173","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/end.2010.0269","volume":"25","author":"M Tobias-Machado","year":"2011","unstructured":"Tobias-Machado, M. et al. Single-site video endoscopic inguinal lymphadenectomy: initial report. J. Endourol. 25, 607\u2013610 (2011).","journal-title":"J. Endourol."},{"key":"246_CR174","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1089\/end.2007.0386","volume":"22","author":"M Tobias-Machado","year":"2008","unstructured":"Tobias-Machado, M. et al. Can video endoscopic inguinal lymphadenectomy achieve a lower morbidity than open lymph node dissection in penile cancer patients? J. Endourol. 22, 1687\u20131691 (2008).","journal-title":"J. Endourol."},{"key":"246_CR175","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bju.13660","volume":"119","author":"V Kumar","year":"2017","unstructured":"Kumar, V. & Sethia, K. K. Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period. BJU Int. 119, 530\u2013534 (2017).","journal-title":"BJU Int."},{"key":"246_CR176","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2017.04.022","volume":"106","author":"CM Russell","year":"2017","unstructured":"Russell, C. M. et al. Minimally invasive inguinal lymphadenectomy in the management of penile carcinoma. Urology 106, 113\u2013118 (2017).","journal-title":"Urology"},{"key":"246_CR177","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.juro.2006.10.075","volume":"177","author":"M Tobias-Machado","year":"2007","unstructured":"Tobias-Machado, M. et al. Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. J. Urol. 177, 953\u2013957 (2007).","journal-title":"J. Urol."},{"key":"246_CR178","volume":"98","author":"J Hu","year":"2019","unstructured":"Hu, J. et al. Comparison of clinical feasibility and oncological outcomes between video endoscopic and open inguinal lymphadenectomy for penile cancer: a systematic review and meta-analysis. Medicine 98, e15862 (2019).","journal-title":"Medicine"},{"key":"246_CR179","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.urology.2013.05.021","volume":"82","author":"K Yao","year":"2013","unstructured":"Yao, K. et al. Fascia lata preservation during inguinal lymphadenectomy for penile cancer: rationale and outcome. Urology 82, 642\u2013647 (2013).","journal-title":"Urology"},{"key":"246_CR180","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.euf.2018.02.002","volume":"5","author":"SR Ottenhof","year":"2019","unstructured":"Ottenhof, S. R. et al. Surgical and oncological outcomes in patients after vascularised flap reconstruction for locoregionally advanced penile cancer. Eur. Urol. Focus. 5, 867\u2013874 (2019).","journal-title":"Eur. Urol. Focus."},{"issue":"Suppl. 1","key":"246_CR181","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.21037\/tau.2019.01.05","volume":"8","author":"HM Alnajjar","year":"2019","unstructured":"Alnajjar, H. M. et al. Long-term outcomes for penile cancer patients presenting with advanced N3 disease requiring a myocutaneous flap reconstruction or primary closure-a retrospective single centre study. Transl. Androl. Urol. 8 (Suppl. 1), S13\u2013S21 (2019).","journal-title":"Transl. Androl. Urol."},{"key":"246_CR182","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archsurg.2010.84","volume":"145","author":"S Yegiyants","year":"2010","unstructured":"Yegiyants, S., Romero, L. M., Haigh, P. I. & DiFronzo, L. A. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Arch. Surg. 145, 564\u2013569 (2010).","journal-title":"Arch. Surg."},{"key":"246_CR183","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.sla.0000128302.05898.a7","volume":"239","author":"K Fournier","year":"2004","unstructured":"Fournier, K., Schiller, A., Perry, R. R. & Laronga, C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann. Surg. 239, 859\u2013863 (2004).","journal-title":"Ann. Surg."},{"key":"246_CR184","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","volume":"177","author":"AP Lont","year":"2007","unstructured":"Lont, A. P. et al. Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J. Urol. 177, 947\u2013952 (2007).","journal-title":"J. Urol."},{"key":"246_CR185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","volume":"15","author":"A Necchi","year":"2017","unstructured":"Necchi, A. et al. Clinical outcomes of perioperative chemotherapy in patients with locally advanced penile squamous-cell carcinoma: results of a multicenter analysis. Clin. Genitourin. Cancer 15, 548\u2013555.e543 (2017).","journal-title":"Clin. Genitourin. Cancer"},{"key":"246_CR186","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","volume":"14","author":"N Nicolai","year":"2016","unstructured":"Nicolai, N. et al. A combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings. Clin. Genitourin. Cancer 14, 323\u2013330 (2016).","journal-title":"Clin. Genitourin. Cancer"},{"key":"246_CR187","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","volume":"109","author":"S Nicholson","year":"2013","unstructured":"Nicholson, S. et al. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001). Br. J. Cancer 109, 2554\u20132559 (2013).","journal-title":"Br. J. Cancer"},{"key":"246_CR188","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","volume":"13","author":"RS Djajadiningrat","year":"2015","unstructured":"Djajadiningrat, R. S., Bergman, A. M., van Werkhoven, E., Vegt, E. & Horenblas, S. Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer. Clin. Genitourin. Cancer 13, 44\u201349 (2015).","journal-title":"Clin. Genitourin. Cancer"},{"key":"246_CR189","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/JU.0000000000000746","volume":"203","author":"M Azizi","year":"2020","unstructured":"Azizi, M. et al. Systematic review and meta-analysis-is there a benefit in using neoadjuvant systemic chemotherapy for locally advanced penile squamous cell carcinoma? J. Urol. 203, 1147\u20131155 (2020).","journal-title":"J. Urol."},{"key":"246_CR190","doi-asserted-by":"crossref","first-page":"531.e7","DOI":"10.1016\/j.urolonc.2019.04.003","volume":"37","author":"A Necchi","year":"2019","unstructured":"Necchi, A. et al. Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: a retrospective multicenter study. Urol. Oncol. 37, 531.e7\u2013531.e15 (2019).","journal-title":"Urol. Oncol."},{"key":"246_CR191","first-page":"733","volume":"68","author":"HD Homesley","year":"1986","unstructured":"Homesley, H. D., Bundy, B. N., Sedlis, A. & Adcock, L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet. Gynecol. 68, 733\u2013740 (1986).","journal-title":"Obstet. Gynecol."},{"key":"246_CR192","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","volume":"114","author":"C Kunos","year":"2009","unstructured":"Kunos, C., Simpkins, F., Gibbons, H., Tian, C. & Homesley, H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet. Gynecol. 114, 537\u2013546 (2009).","journal-title":"Obstet. Gynecol."},{"key":"246_CR193","doi-asserted-by":"crossref","first-page":"605.e17","DOI":"10.1016\/j.urolonc.2017.06.001","volume":"35","author":"DH Tang","year":"2017","unstructured":"Tang, D. H. et al. Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol. Oncol. 35, 605.e17\u2013605.e23 (2017).","journal-title":"Urol. Oncol."},{"key":"246_CR194","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000475360","volume":"26","author":"JN Kulkarni","year":"1994","unstructured":"Kulkarni, J. N. & Kamat, M. R. Prophylactic bilateral groin node dissection versus prophylactic radiotherapy and surveillance in patients with N0 and N1-2A carcinoma of the penis. Eur. Urol. 26, 123\u2013128 (1994).","journal-title":"Eur. Urol."},{"key":"246_CR195","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.juro.2010.10.059","volume":"185","author":"NM Graafland","year":"2011","unstructured":"Graafland, N. M. et al. Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J. Urol. 185, 888\u2013893 (2011).","journal-title":"J. Urol."},{"key":"246_CR196","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","volume":"186","author":"KN Franks","year":"2011","unstructured":"Franks, K. N. et al. Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J. Urol. 186, 524\u2013529 (2011).","journal-title":"J. Urol."},{"key":"246_CR197","doi-asserted-by":"crossref","first-page":"92.e11","DOI":"10.1016\/j.urolonc.2017.11.005","volume":"36","author":"BR Winters","year":"2018","unstructured":"Winters, B. R. et al. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database. Urol. Oncol. 36, 92.e11\u201392.e16 (2018).","journal-title":"Urol. Oncol."},{"key":"246_CR198","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2020.38.15_suppl.5088","volume":"38","author":"P Giannatempo","year":"2020","unstructured":"Giannatempo, P. et al. Impact of human papillomavirus (HPV) infection on the outcome of perioperative treatments for penile squamous-cell carcinoma (PSCC). J. Clin. Oncol. 38, 5088\u20135088 (2020).","journal-title":"J. Clin. Oncol."},{"key":"246_CR199","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","volume":"5","author":"DJ Canter","year":"2019","unstructured":"Canter, D. J., Nicholson, S., Watkin, N., Hall, E. & Pettaway, C. The International Penile advanced cancer trial (InPACT): rationale and current status. Eur. Urol. Focus. 5, 706\u2013709 (2019).","journal-title":"Eur. Urol. Focus."},{"key":"246_CR200","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1200\/JCO.2018.36.15_suppl.4514","volume":"36","author":"LM Pickering","year":"2018","unstructured":"Pickering, L. M. et al. VinCaP: a phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis (CRUK\/12\/021). J. Clin. Oncol. 36, 4514\u20134514 (2018).","journal-title":"J. Clin. Oncol."},{"key":"246_CR201","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","volume":"19","author":"C Theodore","year":"2008","unstructured":"Theodore, C. et al. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann. Oncol. 19, 1304\u20131307 (2008).","journal-title":"Ann. Oncol."},{"key":"246_CR202","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","volume":"60","author":"G Di Lorenzo","year":"2011","unstructured":"Di Lorenzo, G. et al. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur. Urol. 60, 1280\u20131284 (2011).","journal-title":"Eur. Urol."},{"key":"246_CR203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/PHM.0b013e31826edd97","volume":"92","author":"JC Brown","year":"2013","unstructured":"Brown, J. C., Chu, C. S., Cheville, A. L. & Schmitz, K. H. The prevalence of lymphedema symptoms among survivors of long-term cancer with or at risk for lower limb lymphedema. Am. J. Phys. Med. Rehabil. 92, 223\u2013231 (2013).","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"246_CR204","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.clgc.2017.04.010","volume":"15","author":"DL Dr\u00e4ger","year":"2017","unstructured":"Dr\u00e4ger, D. L., Protzel, C. & Hakenberg, O. W. Identifying psychosocial distress and stressors using distress-screening instruments in patients with localized and advanced penile cancer. Clin. Genitourin. Cancer 15, 605\u2013609 (2017).","journal-title":"Clin. Genitourin. Cancer"},{"key":"246_CR205","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2490-9-8","volume":"9","author":"SB Maddineni","year":"2009","unstructured":"Maddineni, S. B., Lau, M. M. & Sangar, V. K. Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol. 9, 8 (2009).","journal-title":"BMC Urol."},{"key":"246_CR206","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eururo.2016.09.048","volume":"73","author":"AS Parnham","year":"2018","unstructured":"Parnham, A. S. et al. Glansectomy and split-thickness skin graft for penile cancer. Eur. Urol. 73, 284\u2013289 (2018).","journal-title":"Eur. Urol."},{"key":"246_CR207","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.juro.2014.04.083","volume":"192","author":"J Yang","year":"2014","unstructured":"Yang, J. et al. Glans preservation contributes to postoperative restoration of male sexual function: a multicenter clinical study of glans preserving surgery. J. Urol. 192, 1410\u20131417 (2014).","journal-title":"J. Urol."},{"key":"246_CR208","volume":"6","author":"C Yu","year":"2016","unstructured":"Yu, C. et al. Sexual function after partial penectomy: a prospectively study from China. Sci. Rep. 6, 21862 (2016).","journal-title":"Sci. Rep."},{"key":"246_CR209","doi-asserted-by":"crossref","first-page":"448","DOI":"10.21037\/tau.2019.09.04","volume":"8","author":"HM Alnajjar","year":"2019","unstructured":"Alnajjar, H. M. et al. A novel \u2018Batman\u2019 scrotectomy technique for the management of scrotal lymphoedema following treatment for penile cancer. Transl. Androl. Urol. 8, 448\u2013456 (2019).","journal-title":"Transl. Androl. Urol."},{"key":"246_CR210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","volume":"8","author":"O Kayes","year":"2007","unstructured":"Kayes, O., Ahmed, H. U., Arya, M. & Minhas, S. Molecular and genetic pathways in penile cancer. Lancet Oncol. 8, 420\u2013429 (2007).","journal-title":"Lancet Oncol."},{"key":"246_CR211","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","volume":"27","author":"FL Sand","year":"2018","unstructured":"Sand, F. L., Rasmussen, C. L., Frederiksen, M. H., Andersen, K. K. & Kjaer, S. K. Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 27, 1123\u20131132 (2018).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"246_CR212","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.juro.2018.09.056","volume":"201","author":"JM Jacob","year":"2019","unstructured":"Jacob, J. M. et al. Comparative genomic profiling of refractory and metastatic penile and nonpenile cutaneous squamous cell carcinoma: implications for selection of systemic therapy. J. Urol. 201, 541\u2013548 (2019).","journal-title":"J. Urol."},{"key":"246_CR213","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.euf.2016.08.001","volume":"4","author":"A Necchi","year":"2018","unstructured":"Necchi, A. et al. Gene expression profiling of advanced penile squamous cell carcinoma receiving cisplatin-based chemotherapy improves prognostication and identifies potential therapeutic targets. Eur. Urol. Focus. 4, 733\u2013736 (2018).","journal-title":"Eur. Urol. Focus."},{"key":"246_CR214","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/j.clgc.2019.10.014","volume":"18","author":"MW De Bacco","year":"2020","unstructured":"De Bacco, M. W. et al. PD-L1 and p16 expression in penile squamous cell carcinoma from an endemic region. Clin. Genitourin. Cancer 18, e254\u2013e259 (2020).","journal-title":"Clin. Genitourin. Cancer"},{"key":"246_CR215","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.3390\/jcm9103334","volume":"9","author":"ME Ahmed","year":"2020","unstructured":"Ahmed, M. E., Falasiri, S., Hajiran, A., Chahoud, J. & Spiess, P. E. The immune microenvironment in penile cancer and rationale for immunotherapy. J. Clin. Med. 9, 3334 (2020).","journal-title":"J. Clin. Med."},{"key":"246_CR216","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.euo.2018.07.010","volume":"2","author":"S Davidsson","year":"2019","unstructured":"Davidsson, S. et al. PD-L1 expression in men with penile cancer and its association with clinical outcomes. Eur. Urol. Oncol. 2, 214\u2013221 (2019).","journal-title":"Eur. Urol. Oncol."},{"key":"246_CR217","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","volume":"197","author":"SR Ottenhof","year":"2017","unstructured":"Ottenhof, S. R. et al. Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status. J. Urol. 197, 690\u2013697 (2017).","journal-title":"J. Urol."},{"key":"246_CR218","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2016.09.003","volume":"59","author":"M Cocks","year":"2017","unstructured":"Cocks, M. et al. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort. Hum. Pathol. 59, 55\u201361 (2017).","journal-title":"Hum. Pathol."},{"key":"246_CR219","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clgc.2016.03.005","volume":"14","author":"A Necchi","year":"2016","unstructured":"Necchi, A. et al. Prognostic factors of adjuvant taxane, cisplatin, and 5-fluorouracil chemotherapy for patients with penile squamous cell carcinoma after regional lymphadenectomy. Clin. Genitourin. Cancer 14, 518\u2013523 (2016).","journal-title":"Clin. Genitourin. Cancer"},{"key":"246_CR220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MOU.0000000000000712","volume":"30","author":"A Thomas","year":"2020","unstructured":"Thomas, A., Vanthoor, J., Vos, G., Tsaur, I. & Albersen, M. Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy. Curr. Opin. Urol. 30, 202\u2013207 (2020).","journal-title":"Curr. Opin. Urol."},{"key":"246_CR221","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel, A. S. et al. Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy. Cancer Res. 75, 5219\u20135227 (2015).","journal-title":"Cancer Res."},{"key":"246_CR222","volume":"11","author":"T Huang","year":"2020","unstructured":"Huang, T. et al. Effective combinatorial immunotherapy for penile squamous cell carcinoma. Nat. Commun. 11, 2124 (2020).","journal-title":"Nat. Commun."},{"key":"246_CR223","doi-asserted-by":"crossref","first-page":"11375","DOI":"10.1007\/s13277-016-4951-z","volume":"37","author":"JJ Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz, J. J. et al. A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma. Tumour Biol. 37, 11375\u201311384 (2016).","journal-title":"Tumour Biol."},{"key":"246_CR224","doi-asserted-by":"crossref","first-page":"51687","DOI":"10.18632\/oncotarget.10098","volume":"7","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis. Oncotarget 7, 51687\u201351698 (2016).","journal-title":"Oncotarget"},{"key":"246_CR225","volume":"9","author":"QH Zhou","year":"2018","unstructured":"Zhou, Q. H. et al. Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines. Cell Death Dis. 9, 684 (2018).","journal-title":"Cell Death Dis."},{"key":"246_CR226","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2020.05.033","volume":"78","author":"A Thomas","year":"2020","unstructured":"Thomas, A. et al. Establishment, characterization, and imaging of a first platinum-resistant penile cancer patient-derived xenograft in nude mice: a eUROGEN project. Eur. Urol. 78, 294\u2013296 (2020).","journal-title":"Eur. Urol."},{"key":"246_CR227","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1200\/JCO.2020.38.15_suppl.5018","volume":"38","author":"BA McGregor","year":"2020","unstructured":"McGregor, B. A. et al. Phase II study of nivolumab and ipilimumab for advanced rare genitourinary cancers. J. Clin. Oncol. 38, 5018\u20135018 (2020).","journal-title":"J. Clin. Oncol."},{"key":"246_CR228","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1200\/JCO.2020.38.15_suppl.101","volume":"38","author":"S Norberg","year":"2020","unstructured":"Norberg, S. et al. Safety and clinical activity of gene-engineered T-cell therapy targeting HPV-16 E7 for epithelial cancers. J. Clin. Oncol. 38, 101\u2013101 (2020).","journal-title":"J. Clin. Oncol."},{"key":"246_CR229","doi-asserted-by":"crossref","first-page":"531.e9","DOI":"10.1016\/j.urolonc.2017.03.002","volume":"35","author":"RA Campbell","year":"2017","unstructured":"Campbell, R. A. et al. Disparity between pre-existing management of penile cancer and NCCN guidelines. Urol. Oncol. 35, 531.e9\u2013531.e14 (2017).","journal-title":"Urol. Oncol."},{"key":"246_CR230","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00432-019-02864-9","volume":"145","author":"M Bada","year":"2019","unstructured":"Bada, M. et al. Adherence to the EAU guidelines on penile cancer treatment: European, multicentre, retrospective study. J. Cancer Res. Clin. Oncol. 145, 921\u2013926 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"246_CR231","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bju.12449","volume":"114","author":"V Tang","year":"2014","unstructured":"Tang, V. et al. Should centralized histopathological review in penile cancer be the global standard? BJU Int. 114, 340\u2013343 (2014).","journal-title":"BJU Int."},{"key":"246_CR232","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1308\/003588410X12518836439047","volume":"92","author":"AC Bayles","year":"2010","unstructured":"Bayles, A. C. & Sethia, K. K. The impact of improving outcomes guidance on the management and outcomes of patients with carcinoma of the penis. Ann. R. Coll. Surg. Engl. 92, 44\u201345 (2010).","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"246_CR233","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.surge.2014.01.007","volume":"13","author":"KJ Breen","year":"2015","unstructured":"Breen, K. J. et al. Penile cancer \u2014 guideline adherence produces optimum results. Surgeon 13, 200\u2013206 (2015).","journal-title":"Surgeon"},{"key":"246_CR234","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2017.5608","volume":"4","author":"SS Joshi","year":"2018","unstructured":"Joshi, S. S. et al. Treatment trends and outcomes for patients with lymph node-positive cancer of the penis. JAMA Oncol. 4, 643\u2013649 (2018).","journal-title":"JAMA Oncol."},{"key":"246_CR235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.euo.2018.10.006","volume":"2","author":"SB Williams","year":"2019","unstructured":"Williams, S. B. et al. Impact of centralizing care for genitourinary malignancies to high-volume providers: a systematic review. Eur. Urol. Oncol. 2, 265\u2013273 (2019).","journal-title":"Eur. Urol. Oncol."},{"key":"246_CR236","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.euf.2019.01.013","volume":"5","author":"MH Kamel","year":"2019","unstructured":"Kamel, M. H. Should the care of penile cancer be confined to centralized centers of excellence? Eur. Urol. Focus. 5, 735\u2013736 (2019).","journal-title":"Eur. Urol. Focus."},{"key":"246_CR237","first-page":"646","volume":"115","author":"OW Hakenberg","year":"2018","unstructured":"Hakenberg, O. W. et al. The diagnosis and treatment of penile cancer. Dtsch. Arztebl. Int. 115, 646\u2013652 (2018).","journal-title":"Dtsch. Arztebl. Int."},{"key":"246_CR238","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.humpath.2012.01.014","volume":"43","author":"A Chaux","year":"2012","unstructured":"Chaux, A. & Cubilla, A. L. Advances in the pathology of penile carcinomas. Hum. Pathol. 43, 771\u2013789 (2012).","journal-title":"Hum. Pathol."},{"key":"246_CR239","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/PAS.0b013e318249c6f3","volume":"36","author":"AL Cubilla","year":"2012","unstructured":"Cubilla, A. L. et al. Basaloid squamous cell carcinoma of the penis with papillary features: a clinicopathologic study of 12 cases. Am. J. Surg. Pathol. 36, 869\u2013875 (2012).","journal-title":"Am. J. Surg. Pathol."},{"key":"246_CR240","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/his.13429","volume":"72","author":"AL Cubilla","year":"2018","unstructured":"Cubilla, A. L. et al. The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology 72, 893\u2013904 (2018).","journal-title":"Histopathology"},{"key":"246_CR241","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.biocel.2007.07.004","volume":"39","author":"G Boulet","year":"2007","unstructured":"Boulet, G., Horvath, C., Vanden Broeck, D., Sahebali, S. & Bogers, J. Human papillomavirus: E6 and E7 oncogenes. Int. J. Biochem. Cell Biol. 39, 2006\u20132011 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"246_CR242","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ncpuro0261","volume":"2","author":"DJ Summerton","year":"2005","unstructured":"Summerton, D. J., Campbell, A., Minhas, S. & Ralph, D. J. Reconstructive surgery in penile trauma and cancer. Nat. Clin. Pract. Urol. 2, 391\u2013397 (2005).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"246_CR243","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/cpr.13.95","volume":"11","author":"P Hadway","year":"2014","unstructured":"Hadway, P., Sahdev, V., Arya, M. & Muneer, A. Recent developments and current management of penile cancer. Clin. Pract. 11, 169\u2013181 (2014).","journal-title":"Clin. Pract."},{"key":"246_CR244","doi-asserted-by":"crossref","unstructured":"Kirkham, A. P. S. in Textbook of Penile Cancer (eds Muneer, A. & Horenblas, S.) 89-114 (Springer, 2016).","DOI":"10.1007\/978-3-319-33220-8_8"},{"key":"246_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.06.025","author":"J Crook","year":"2020","unstructured":"Crook, J. Organ preserving radiation strategies for penile cancer. Urol. Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2020.06.025 (2020).","journal-title":"Urol. Oncol."},{"key":"246_CR246","first-page":"440","volume":"40","author":"OG Dodge","year":"1963","unstructured":"Dodge, O. G., Linsell, C. A. & Davies, J. N. Circumcision and the incidence of carcinoma of the penis and the cervix. a study in Kenya and Uganda Africans. East Afr. Med. J. 40, 440\u2013444 (1963).","journal-title":"East Afr. Med. J."},{"key":"246_CR247","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(01)24346-3","volume":"219","author":"A Wolbarst","year":"1932","unstructured":"Wolbarst, A. Circumcision and penile cancer. Lancet 219, 150\u2013153 (1932).","journal-title":"Lancet"},{"key":"246_CR248","first-page":"180","volume":"7","author":"R Schrek","year":"1947","unstructured":"Schrek, R. & Lenowitz, H. Etiologic factors in carcinoma of the penis. Cancer Res. 7, 180\u2013187 (1947).","journal-title":"Cancer Res."},{"key":"246_CR249","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49, 1603\u20131616 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"246_CR250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav, E. et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759\u2013771 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"246_CR251","first-page":"E76","volume":"12","author":"S Dave","year":"2018","unstructured":"Dave, S., Afshar, K., Braga, L. H. & Anderson, P. Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version). Can. Urol. Assoc. J. 12, E76\u2013E99 (2018).","journal-title":"Can. Urol. Assoc. J."},{"key":"246_CR252","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","volume":"346","author":"X Castellsagu\u00e9","year":"2002","unstructured":"Castellsagu\u00e9, X. et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N. Engl. J. Med. 346, 1105\u20131112 (2002).","journal-title":"N. Engl. J. Med."},{"key":"246_CR253","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.juro.2009.09.030","volume":"183","author":"SM Doyle","year":"2010","unstructured":"Doyle, S. M., Kahn, J. G., Hosang, N. & Carroll, P. R. The impact of male circumcision on HIV transmission. J. Urol. 183, 21\u201326 (2010).","journal-title":"J. Urol."},{"key":"246_CR254","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1521\/aeap.2018.30.3.232","volume":"30","author":"I Schenker","year":"2018","unstructured":"Schenker, I. Cutting-edge success in preventing heterosexual HIV transmission in Africa: voluntary medical male circumcision has reached 15 million men. AIDS Educ. Prev. 30, 232\u2013242 (2018).","journal-title":"AIDS Educ. Prev."},{"key":"246_CR255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J. Clin. 67, 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-021-00246-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-021-00246-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-021-00246-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T20:53:02Z","timestamp":1697835182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-021-00246-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":255,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1038\/s41572-021-00246-5","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"12 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.: eUROGEN clinical lead on rare urogenital cancer workstream (WS3); <i>Nature Reviews Urology<\/i> advisory board member; <i>European Urology<\/i> Associate Editor; EAU Scientific Office member; EAU\u2013ASCO penile cancer guideline panel member. A.Th.: EUSP scholar. A.M.: eUROGEN research lead on rare urogenital cancer workstream (WS3); ESMO penile cancer guideline panel member; editorial board <i>BJU International<\/i>. A.N.: EAU\u2013ASCO penile cancer guideline panel member, penile cancer research funding to institute by Ipsen and Pfizer. P.E.S.: NCCN penile cancer guideline discussion writing committee member; EAU\u2013ASCO penile cancer guideline panel member; <i>Nature Reviews Urology<\/i> advisory board member. M.T.-M.: coordinator of Penile Cancer Collaborative Coalition \u2013 Latin America. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}